Celanese stock
CENYSECelanese Corporation, Basic MaterialsISIN US1508701034
52Score 52 out of 100, Neutral
Price and trend
64 / 100
Price history
+31% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 0.9% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 61).
The price is 26% below its 52-week high. Largest decline in 20 years: 85% (June 2008 to March 2009).
Chart figures for advanced users
- SMA 50$46.74
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$51.70
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)61
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$35.53
- The lowest closing price of the last twelve months.
- Resistance$69.24
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Celanese Corporation belongs to the Chemicals industry (United States) and, with a market value of $5.62B, is number 23 of 44 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $9.54B (down 7.2% year on year) and a loss of $1.17B.
- For fiscal 2026, analysts expect on average revenue of $10.04B (up 5.2%) and adjusted earnings per share of $6.06 (up 50.7%).
Show more
- MEQIRI Score 52 out of 100 (Neutral): rank 302 of 467 in Basic Materials, median 58.
- The P/E is 20.8 (Chemicals median 15.6, own median of recent years 9.9).
- Our model puts fair value at $64.62, with the price 20% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings turn into cashFree cash flow 303% of earnings over the last 12 months.Fundamentals 73
- Share buybacksShare count down 7% since 2020.Capital allocation 60
- Growing faster than its industryRevenue up 11% a year since 2020, Chemicals median 2.6%.
Weaknesses
- High debtDebt 2.56 times equity (latest quarter), Chemicals median 0.55.Stability 28
- Turned to a lossEarnings per share from $16.85 in 2020 to −$10.64.Growth 36
- Margin fallingOperating margin 8%, average of the prior years 14.2% (to 2024).Profitability 31
Its standout strengths are fundamentals and valuation, while profitability and stability hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 51 to 52.
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
- high price swings
Valuation
Valuation signal
Modestly undervaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $46.16 and expensive above $107.70 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $90.71 (cash-flow model) and $38.53 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 9.2%. At 10.2% the fair value would be $56.95, at 8.2% it would be $75.83.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (15.6).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 1.4% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 19%, operating 8%, net −12%. Last 12 months: net 3%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 16 Feb 2027in 96 days
- Last reported
- 2 Nov 2026EPS reported $1.65 (expected $1.56)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $6.06+1.1%
- Revenue
- $10.04B+0.1%
- Earnings per share
- $6.24+0.6%
- Revenue
- $10.02B+0.3%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −2.9%No change evident: the expected moderation in the second half is in line with the May plan, 2026 free cash flow of $700 million to $800 million.
“And maybe a question for Chuck on free cash flow and the $700 million to $800 million guidance for 2026.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 5 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
3 insiders bought on the open market between 11 Aug 2026 and 14 Aug 2026, $230,062 in total.
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Celanese
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 52
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals
The next larger and next smaller companies by market value
- Shandong Hualu-Hengsheng Chemical600426.SS $7.86B62
- Ecopro086520.KQ $7.45B28
- Haohua Chemical Science & Technology600378.SS $6.5B58
- Nissan Chemical4021.T $5.88B76
- Tokyo Ohka Kogyo4186.T $5.61B68
- MethanexMEOH $5.34B73
- Sichuan Em Technology601208.SS $5.33B49
- Hoshine Silicon Industry603260.SS $5.22B29
ETFs that hold Celanese
Held by 9 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.28% | 0.30% | €2.28B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.18% | 0.30% | €944.34M |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.05% | 0.35% | €8.19B |
Show 5 more
| Invesco RAFI US Fundamental Value UCITS ETF6PSA | 0.05% | 0.39% | €1.23B |
| Invesco RAFI All-World Fundamental Value UCITS ETFPSWD | 0.03% | 0.39% | €446.84M |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €175.89M |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
| State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)SPYI | 0.00% | 0.17% | €8.6B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Nov 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.